Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Frontiers in Pharmacology | journal | 1.143 Q1 | 154 | 4009 | 5230 | 262406 | 33132 | 5134 | 5.69 | 65.45 | 45.75 | |
2 | Advances in Therapy | journal | 1.032 Q1 | 83 | 389 | 819 | 15754 | 3417 | 766 | 3.94 | 40.50 | 45.40 | |
3 | Vaccines | journal | 1.004 Q1 | 85 | 1502 | 1076 | 91267 | 5345 | 1038 | 4.89 | 60.76 | 46.88 | |
4 | Journal of Cardiovascular Development and Disease | journal | 0.897 Q1 | 32 | 188 | 159 | 10975 | 621 | 153 | 4.21 | 58.38 | 37.60 | |
5 | Antibiotics | journal | 0.785 Q2 | 77 | 1553 | 1305 | 93008 | 6858 | 1277 | 5.08 | 59.89 | 47.93 | |
6 | Inflammopharmacology | journal | 0.772 Q2 | 68 | 138 | 366 | 8645 | 1721 | 360 | 4.66 | 62.64 | 44.32 | |
7 | Chemotherapy | journal | 0.742 Q2 | 61 | 39 | 98 | 1209 | 286 | 95 | 3.06 | 31.00 | 38.20 | |
8 | Drugs - Real World Outcomes | journal | 0.532 Q2 | 21 | 51 | 83 | 1902 | 190 | 80 | 2.05 | 37.29 | 38.01 | |
9 | Cardiology | journal | 0.524 Q2 | 72 | 105 | 344 | 2916 | 511 | 271 | 1.31 | 27.77 | 28.19 | |
10 | PharmacoEconomics - Open | journal | 0.506 Q3 | 20 | 68 | 171 | 2655 | 323 | 155 | 1.74 | 39.04 | 36.78 | |
11 | EJNMMI Radiopharmacy and Chemistry | journal | 0.447 Q3 | 28 | 35 | 76 | 1244 | 370 | 73 | 5.26 | 35.54 | 31.17 | |
12 | WHO Drug Information | journal | 0.118 Q4 | 11 | 12 | 26 | 173 | 3 | 21 | 0.10 | 14.42 | 41.18 | |
13 | Frontiers in Medical Technology | journal | 15 | 81 | 32 | 4779 | 69 | 27 | 2.16 | 59.00 | 37.66 | ||
14 | Medical Cannabis and Cannabinoids | journal | 13 | 15 | 35 | 808 | 153 | 30 | 3.70 | 53.87 | 34.88 | ||
15 | Pharma-Kritik (discontinued) | journal | 2 | 14 | 53 | 127 | 0 | 33 | 0.00 | 9.07 | 33.33 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®